Kelani assumed his current role in 2019. In 2023, EIPICO recorded total sales of $107 million, a 32% growth compared to 2022. The company also announced it would be concluding the implementation of the $100 million EIPICO 3 factory on the 10th of Ramadan City, and establishing a multi-purpose factory to produce raw pharmaceutical materials in Ain Sokhna with the $101 million investments for the first phase. Kelani was previously the chairman and CEO of Medical Union Pharmaceuticals.